Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Mereo BioPharma (MREO) FCF Margin (2023 - 2025)

Mereo BioPharma (MREO) has disclosed FCF Margin for 2 consecutive years, with 1530.2% as the latest value for Q2 2025.

  • Quarterly FCF Margin changed N/A to 1530.2% in Q2 2025 from the year-ago period, while the trailing twelve-month figure was 9684.69% through Dec 2025, changed N/A year-over-year, with the annual reading at 6198.2% for FY2025, N/A changed from the prior year.
  • FCF Margin for Q2 2025 was 1530.2% at Mereo BioPharma, down from 4638.33% in the prior quarter.
  • The five-year high for FCF Margin was 4638.33% in Q1 2025, with the low at 1530.2% in Q2 2025.